M&A Deal Summary |
|
|---|---|
| Date | 2025-08-06 |
| Target | IPA Europe |
| Sector | Business Services |
| Buyer(s) | AVS Bio |
| Sellers(s) | ImmunoPrecise |
| Deal Type | Divestiture |
| Deal Value | 12M USD |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1961 |
| Sector | Life Science |
| Employees | 250 |
AVS Bio is a provider of specific pathogen free eggs and adjacent laboratory products and services that support the development and manufacture of vaccines, therapeutics, and other biologics used for human and animal health. AVS Bio was founded in 1961 and is based in Norwich, Connecticut.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Netherlands M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 1983 |
| Sector | Life Science |
| Employees | 102 |
| Revenue | 25M CAD (2025) |
ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise was founded in 1983 and is based in Victoria, Canada.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Business Services M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Netherlands M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-03-20 |
Carterra s LSA Instrument
Salt Lake City, Utah, United States Carterra's LSA Instrument which allows for high throughput surface plasmon resonance-based antibody characterizations thereby significantly increasing the Company’s capacity in performing various label-free protein interaction analyses including best-in-class kinetics, epitope binning, quantitation, epitope mapping, and blocking/neutralization assays. |
Buy | - |
